You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adoptive Cell Transfer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Tampa (procedure, drug, other)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Surgery
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 6, 2023

    HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

    Recruiting
    • HNSCC
    • +5 more
    • DP CD8 TIL
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 5, 2023

    Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

    Recruiting
    • Gastric Cancer
    • +9 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Fludarabine + Cyclophosphamide combination
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    COVID Trial in Bogotá, Bogota (Allogeneic NK transfer)

    Withdrawn
    • COVID
    • Allogeneic NK transfer
    • Bogotá, Bogotá Distrito Capital, Colombia
    • +1 more
    Apr 29, 2021

    Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

    Not yet recruiting
    • Advanced Melanoma
    • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
    • Basel, Switzerland
      University Hospital Basel
    May 19, 2023

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Advanced NSCLC, Chemo Trial in Xi'an (Chemotherapy, Adoptive TKC transfer therapy)

    Recruiting
    • Advanced Non-small Cell Lung Cancer
    • Chemotherapy
    • Xi'an, Shanxi, China
      Tangdu Hospital, Fourth Military Medical University
    Jul 26, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Phoenix, Arizona
      Mayo Clinic Hospital in Arizona
    Jan 4, 2023

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

    Active, not recruiting
    • Metastatic Melanoma
    • +2 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

    Terminated
    • Colorectal Adenocarcinoma
    • +12 more
    • Adoptive Immunotherapy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 28, 2020

    Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

    Recruiting
    • Lymphoma
    • +2 more
    • Kappa CD28 T cells
    • Houston, Texas
    • +1 more
    Jan 31, 2022

    Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

    Active, not recruiting
    • Malignant Neoplasm
    • aldesleukin
    • +7 more
    • Los Angeles, California
      University of California at Los Angeles (UCLA )
    Dec 1, 2022

    Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

    Recruiting
    • Urothelial Carcinoma
    • Non-Invasive Bladder Urothelial Carcinoma
    • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 2, 2023

    Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

    Active, not recruiting
    • Prostate Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 28, 2022

    Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Uveal Neoplasms
    • Melanoma, Uveal
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      Allyson Welsch
    Jul 21, 2022

    Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

    Recruiting
    • Neuroblastoma
    • Diffuse Intrinsic Pontine Glioma
    • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
    • Gainesville, Florida
    • +1 more
    Apr 20, 2022

    Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

    Recruiting
    • Pancreatic Cancer
    • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
    • Shanghai, China
      Changhai Hospital affiliated to Naval Medical University
    Mar 13, 2023

    Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)

    Recruiting
    • Pediatric Sarcoma, Refractory
    • Pediatric Sarcoma, Relapsed
    • GEM/DOX + TGFBi expanded NK cells
    • Tampa, Florida
    • +1 more
    Jan 3, 2023

    Melanoma Trial in Stockholm (Cyclophosphamide, Fludarabine, T cells)

    Recruiting
    • Melanoma
    • Stockholm, Sweden
      Karolinska University Hospital
    Sep 17, 2020

    HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

    Recruiting
    • HER2-positive Breast Cancer
    • Dendritic Cell (DC1) Vaccine
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 28, 2022

    Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

    Recruiting
    • Advanced Melanoma
    • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
    • Basel, Switzerland
      Division of Medical Oncology and Cancer Immunology, University H
    Aug 3, 2021